First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Clinical trial NCT04858269 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04858269
- Sponsor
- Wake Forest University Health Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2026-06-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.